By Amit Bhatnagar, Founder, Swasthgram Global Foundation
LinkedIn: Amit (Social Entrepreneur) Bhatnagar
LinkedIn: Swasthgram Global Foundation
A 53-year-old woman moved through the ordinary processes of modern medicine in precisely the way the system demands. She had imaging done after suspicious findings appeared on a mammogram, then a biopsy, followed by a pathology report confirming malignancy. The result existed and had not been missed, misread, or hidden beyond the reach of care. It was inside the system, waiting for the system to do what it was meant to do next.
Fifteen months later, the report was found while a resident was clearing a mailbox. By then, the mass had tripled in size, and the patient required surgery and chemotherapy. This is not merely a case of a record being mishandled, but rather a lesson in the increasing importance of medical systems implementation. A clinical finding only becomes care when it is carried forward.
That distinction should sit at the center of the mobile healthcare conversation. It is tempting to think that the hard part of mobile care is preserving the standard of care inside a moving unit, as though the central challenge were transportation. Once care leaves the clinic, the quiet architecture around care has to be rebuilt: training, quality checks, records, referrals, accountability, and the chain by which a result moves from discovery into treatment.
Mobile healthcare is now entering the serious rural-health policy conversation in the United States. CMS is allocating $50 billion through the Rural Health Transformation Program from FY2026 through FY2030. Mobile Health Map, a program of Harvard Medical School, estimates that 3,600 mobile clinics in the U.S. deliver 10 million visits each year. Georgetown’s Center on Health Insurance Reforms found that 42 states included mobile health in their applications, while noting that many plans still offered limited detail on integration, financing, and sustainability.
The current risk is not that mobile care will be ignored, but rather that it will be funded as a visible intervention before it is designed as a clinical system.
The evidence already points in that direction. In one study of mobile mammography, only 45% of patients obtained recommended follow-up within 60 days after an abnormal screening, compared with 72% of fixed-site patients. A rural South Carolina study of a mobile clinic found a related problem with referrals, where the process often depended on individual provider knowledge rather than a consistent infrastructure of records, follow-up, navigation, and receiving providers.
These are not arguments against mobile care, but instead against building the visible parts first, before the system around them is ready. A mobile unit can perform a test, collect a sample, or identify risk. However, without the surrounding system, it can produce a situation where care stops halfway, and reaches the patient just far enough to reveal a problem, but not enough to carry that patient reliably into the next stage.
This is a lesson I learned early in building systems for rural and hard-to-reach communities in India. The approach worked not only as a technology-led solution, but as a self-sufficient, community-driven system for last-mile care. The logistics of transportation, quality control, financial sustainability, training, medical data, and referrals had to be considered. Access to high-quality, affordable care, thus, needs to be backed by a sustainable system, both logistically and financially. In a rural setting, the assumptions behind facility-based care fall apart more quickly than we would like. A patient may lose a day’s wages traveling for a test. Diagnostic access may be distant. Trained staff may be scarce. Power, transport, and follow-up cannot be presumed into existence. And all of these difficulties can drastically affect the quality of care. If a laboratory is to reach the patient, then it cannot arrive alone.
In the programs I worked on, a single unit could run on the order of 200 tests: from vitals like blood pressure and oxygen saturation, to blood panels covering anemia, blood glucose, lipids, and liver and kidney function, to urinalysis and serology for HIV, hepatitis, and locally endemic infections. Yet a broad test menu matters only if the result can be trusted, recorded, interpreted, and acted upon.
The person handling the device matters. My team and I trained thousands of operators through structured laboratory and phlebotomy training programs lasting months rather than years, because mobile care depends on people who can work within a disciplined clinical process, not merely operate a device. These operators then extend the first layer of care by following protocols, collecting samples, running screenings, capturing results, and connecting patients to the next step. Crucially, the strongest versions of this give operators a real stake in the system rather than treating them as interchangeable technicians. When the person running the unit is invested in its success, the clinical process holds together far better.
The same is true of quality control, perhaps the least glamorous and most decisive layer of the model. In mobile diagnostics, daily internal quality control is undertaken before patient sample testing. Furthermore, third-party controls, calibration, maintenance, external quality assessment, documentation, corrective action, and internal audit allow a result generated outside a conventional facility to be trusted inside the wider system.
This is why many mobile and digital health interventions struggle once they move beyond pilots. A 2024 scoping review in Implementation Science noted that mobile health (mHealth) interventions often show promise but rarely translate to scale, with many remaining small, short-term, donor-funded projects. The problem is not just the technology itself, but whether it has been absorbed into ordinary workflows, training, responsibilities, and institutions.
For rural healthcare in the U.S., the next few years should be judged by this standard: not merely how many mobile units are purchased, or how many screenings are performed. Rather, they need to be judged by whether each model has a result-to-action pathway: who receives the result, who reviews it, where the patient goes next, how follow-up is tracked, and whether the encounter becomes care.
The next rural-health breakthrough will not just be another vehicle, device, or app. It will come through the tougher task of combining technology, logistics, and training into a comprehensive system that makes a portable clinical pathway strong enough to survive the journey.